Ultragenyx, based in Novato, California, and GeneTx Biotherapeutics, headquartered in Downers Grove, Illinois, are partnering to advance a therapy for a rare neurogenetic disorder, Angelman syndrome. Ultragenyx will also have the option to acquire GeneTx.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,